Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP363961.RA6iZaTXHzBNmIVimhmHBQoQt-eTmlxJATfgOgfRECf1M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP363961.RA6iZaTXHzBNmIVimhmHBQoQt-eTmlxJATfgOgfRECf1M130_assertion type Assertion NP363961.RA6iZaTXHzBNmIVimhmHBQoQt-eTmlxJATfgOgfRECf1M130_head.
- NP363961.RA6iZaTXHzBNmIVimhmHBQoQt-eTmlxJATfgOgfRECf1M130_assertion description "[Furthermore, some endometrioid carcinomas and serous cystadenocarcinomas of the ovary and some ovarian cancers in stages III and IV expressed remarkably high levels of PD-ECGF and its mRNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363961.RA6iZaTXHzBNmIVimhmHBQoQt-eTmlxJATfgOgfRECf1M130_provenance.
- NP363961.RA6iZaTXHzBNmIVimhmHBQoQt-eTmlxJATfgOgfRECf1M130_assertion evidence source_evidence_literature NP363961.RA6iZaTXHzBNmIVimhmHBQoQt-eTmlxJATfgOgfRECf1M130_provenance.
- NP363961.RA6iZaTXHzBNmIVimhmHBQoQt-eTmlxJATfgOgfRECf1M130_assertion SIO_000772 9563652 NP363961.RA6iZaTXHzBNmIVimhmHBQoQt-eTmlxJATfgOgfRECf1M130_provenance.
- NP363961.RA6iZaTXHzBNmIVimhmHBQoQt-eTmlxJATfgOgfRECf1M130_assertion wasDerivedFrom befree-20150227 NP363961.RA6iZaTXHzBNmIVimhmHBQoQt-eTmlxJATfgOgfRECf1M130_provenance.
- NP363961.RA6iZaTXHzBNmIVimhmHBQoQt-eTmlxJATfgOgfRECf1M130_assertion wasGeneratedBy ECO_0000203 NP363961.RA6iZaTXHzBNmIVimhmHBQoQt-eTmlxJATfgOgfRECf1M130_provenance.